Litigation Details for ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC. (D.N.J. 2016)
✉ Email this page to a colleague
ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-05-06 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-08-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Jose L. Linares |
| Jury Demand | None | Referred To | Joseph A. Dickson |
| Patents | 8,309,122; 8,329,216; 8,808,737 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-10-25 | 27 | issued. U.S. Patent No. 8,309,122 (“ ‘122 Patent”) was issued on November 13, 2012; U.S. Patent No. 8,329,216… (the issued patents being “Existing Patents” and the patent The then-pending patent applications …OPANA bearing U.S. Patent Nos. 5,662,933 (“ ‘933 Patent”) and 5,958,456 (“ ‘456 Patent”) (collectively “… license to any patents issuing from the pending patent applications and other patents [Plaintiff] might…(“ ‘216 Patent”) was issued on December 11, 2012; and U.S. Patent No. 8,808,737 (“ ‘737 Patent”) was issued | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
